Sangamo Therapeutics

In News

Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders - Yahoo Finance

Yahoo Finance - Jun 08, 2026

PTC Wins Sangamo's Fabry Gene Therapy in Bankruptcy Auction - CGTLive®

CGTLive® - Aug 24, 2026

Case Summary: Sangamo Therapeutics Chapter 11 - Bondoro

Bondoro - Jun 24, 2026

UPDATE: Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy - BioSpace

BioSpace - Jun 23, 2026

Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers - Fierce Biotech

Fierce Biotech - Jun 23, 2026

Sangamo Approved to Sell Fabry Disease Program for $111 Million - Bloomberg Law News

Bloomberg Law News - Sep 03, 2026

PTC takes a chance on Sangamo’s Fabry disease gene therapy - BioPharma Dive

BioPharma Dive - Aug 13, 2026

Gene Editing Pioneer Sangamo Files for Chapter 11 Bankruptcy; Agrees to Sell Assets - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jun 23, 2026

Rx Rundown: Merck KGaA, AbbVie, Sangamo Therapeutics and more - mmm-online.com

mmm-online.com - Jun 26, 2026

Sangamo Therapeutics stock falls after Nasdaq delisting to OTC market - ad-hoc-news.de

ad-hoc-news.de - Sep 19, 2026

Sangamo Therapeutics to Sell ST-920 Fabry Assets to PTC for $111 Million Plus Milestones - TradingView

TradingView - Aug 28, 2026

Sangamo seeks accelerated US approval of gene therapy for Fabry - Fabry Disease News

Fabry Disease News - Mar 12, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment